期刊文献+

地高辛对心肌梗死后不同程度心功能损伤大鼠生存率的影响

Effect of Digitalis Treatment on the Survival of Myocardial Infavction Rats with Different Cardiac Function
原文传递
导出
摘要 目的:探讨地高辛对心肌梗死后不同程度心功能损伤大鼠生存率的影响。方法:60只Wistar大鼠进行心梗模型建立后被随机分为对照组30例及试验组30例,观察不同心梗面积及不同心功能下地高辛对大鼠生存率的作用。结果:在梗死面积≥37%时,使用地高辛治疗与对照组比较能提高大鼠的存活率(61.3%vs 40%);超声心动图显示FAC≤37%、E/A比值≥3.04、LVDD≥0.82cm、LVSD≥0.62cm及LVSA≥0.26cm2组别中,其280d生存率仍分别维持在60%左右,与对照组的17%-32%的生存率有着显著的提高。结论:地高辛治疗能提高心功能受损程度较严重(心肌梗死面积梗死面积≥37%)心肌梗死后大鼠生存率。 Objective: To explore the effect of digitalis treatment on the survival rate of rats with different cardiac function after myocardial infarction. Methods: The myocardial infarction models were established in 60 Wistar rats, which were divided equally into digoxin treatment group and control group. The 280-day survival rates of rats were analyzed according to different myocardial infarct (MI) size and different heart function. Results: In the rats with MI size≥37%, the digoxin treatment can improve the survival rate from 40% to 61.3%. In the rats with echocardiographic indices such as FAC≤37%, E/A ratio≥3.04 LVDD≥0.82 cm, LVSD≥0.62 cm and LVSA≥0.26 cm^2, the survival rate in digoxin treatment group remained about 60%, which was significantly higher than 17%-32% in control group. Conclusion: Digitalis therapy can improve the survival rate of rats with large area myocardial infarction or with poor cardiac function.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2014年第2期178-182,共5页 Medical Journal of Wuhan University
关键词 地高辛 心肌梗死 心功能 生存率 Digitalis Myocardial Infarction Cardiac Function Survival Rate
  • 相关文献

参考文献15

二级参考文献42

  • 1龚浩,欧阳定安,胡威.胺碘酮联合依那普利预防阵发性心房颤动复发的临床观察[J].中国循环杂志,2004,19(6):415-415. 被引量:9
  • 2Xu Li,Ying Meng,Xi-Shan Yang,Ling-Fei Mi,Shao-Xi Cai.ACEI attenuates the progression of CCl_4-induced rat hepatic fibrogenesis by inhibiting TGF-β1, PDGF-BB, NF-κB and MMP-2,9[J].World Journal of Gastroenterology,2005,11(31):4807-4811. 被引量:12
  • 3Yin WH, Chen JW, Jen HL, et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure[J]. Am Heart J,2004,147(5) :931 -938.
  • 4Braunwald E, Bristow MR. Congestive heart failure :fifty years of progress [ J ]. Circulation,2000,102 (20 Suppl 4 ) : 14 - 23.
  • 5Kjekshus J,Apetrei E, Barrios V,et al. Rosuvastatin in older patients with systolie heart failure[ J]. N Engl J Med,2007, 357(22) :2 248 -2 261.
  • 6Khush KK,Waters DD, Bittner V, et al. Effect of high-dose atorvastatin on hospitalizations for heart failure. Subgroup analysis of the Treating to New Targets (TNT) Study [ J ]. Circulation, 2007,115 ( 5 ) :576 - 583.
  • 7Von Haehling S,Anker SD, Bassenge E. Statins and the role of nitric oxide in chronic heart failure[J]. Heart Fail Rev, 2003,8( 1 ) :99 - 106.
  • 8Nachtigal P, Kopecky M, Solichova D,et al. The changes in the endothelialex, pression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atheroselerosis [ J ]. J Pharm Pharmaco1,2005,57 ( 2 ) : 197 - 203.
  • 9Habibi J, Whaley-Connell A, Qazi MA, et al. Rosuvastatin, a 3-hydiroxy-3-methylglutaryl coenz3nne a reduetase inhibitor,decreases cardiac oxldallve stress and remodeling in Renz transgenic rats[J]. Endocrinology,2007,148(5):2 181 -2 188.
  • 10Ramani G, Zahid M, Good CB, et al. Comparison offrequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome [J ]. Am J Cardio1,2007,100 ( 3 ) :404 - 405.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部